Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) at Colorado State University (CSU) is committed to ensuring that activities of a potentially biologically hazardous nature are conducted safely and responsibly. To fulfill this commitment the IBC reviews, approves, and maintains a record of all research and teaching activities by faculty, staff and students, that utilize infectious agents, human body fluids or tissues, and recombinant DNA molecules. Reviews are conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) and the CDC/OHS Biosafety in Microbiological and Biomedical Laboratories (BMBL). This review process ensures that all activities involving these materials and the facilities used to conduct such work are in compliance with current federal regulations and applicable CSU policies.